BioHistory Moment: Diamond v. Chakrabarty case argued before U.S. Supreme Court
On March 17, 1980, the Diamond v. Chakrabarty case was argued before the U.S. Supreme Court regarding the
patentability of genetically altered microorganisms.
In 1972, Chakrabarty filed a patent application assigned to the General Electric Co. for a human-made genetically
engineered bacterium capable of breaking down multiple components of crude oil. The application asserted 36 claims
related to Chakrabarty's invention of a bacterium from the genus Pseudomonas containing at least two
stable energy-generating plasmids, each of said plasmids providing a separate hydrocarbon degradative pathway.
On June 16, 1980, the U.S. Supreme Court upheld five-to-four the patentability of genetically altered organisms,
opening the door to greater patent protection for any modified life forms. Chief Justice Warren Burger
delivered the opinion of the Court, in which justices Potter Stewart, Harry Blackmun, William Rehnquist, and
John Paul Stevens joined. William Brennan filed the dissenting opinion, in which Byron White, Thurgood Marshall,
and Lewis Powell joined.
 More...
Learn about Sacramento's Embarcadero Road Biotech/Medical Device Facility
The Embarcadero Road biotech/medical device facility, located just off Riverside Parkway and Interstate 80, ecompasses
425,146 square feet on 9.76 Acres. This unique facility offers office, laboratory, manufacturing, and assembly space, plus
cleanrooms to address your every need. This facility is located in a state designated Enterprise Zone, and the West Sacrament
Redevelopment Area/Targeted Employment Zone providing additional incentives and benefits for your company.
Learn about biotechnology, medical device and pharmaceutical facilities available for sale,
lease or sublease in Utah, regionally or nationwide.
More...
(Advertising)
|
|
|
Industry News...
Free News Release Posting & Archiving Service
- Accelrys announces latest release of Its leading discovery studio(R) application Accelrys announced the release of Accelrys Discovery Studio(R)2.5.5, the most advanced computational chemistry and biology software application for drug discovery. This release features new algorithmic developments in the protein modeling area.
Accelrys, Inc. March 16, 2010
- Neurocrine Biosciences announces exercise of over-allotment option for common stock Neurocrine Biosciences announced that the underwriter of its recently completed public offering of common stock has exercised in full its option to purchase an additional 1,365,000 shares of common stock to cover over-allotments with gross proceeds of approximately $23 million.
Neurocrine Biosciences, Inc. March 16, 2010
- BioTime reports publication on the reversal of the development BioTime announced the publication of a scientific paper itled "Spontaneous Reversal of Developmental Aging in Normal Human Cells Following Transcriptional Reprogramming." The article was released online in the peer-reviewed journal Regenerative Medicine in advance of the print publication.
BioTime, Inc. March 16, 2010
- XOMA receives notice of non-compliance from NASDAQ XOMA announced that it has received a Staff Determination letter from The NASDAQ Stock Market indicating that the company has not regained compliance with the minimum $1.00 per share requirement for continued inclusion on The NASDAQ Global Market, pursuant to NASDAQ Listing.
XOMA Ltd. March 16, 2010
- Founder of UCLA's Jonsson Comprehensive Cancer Center dead at 79 Kenneth A. Jonsson, who along with his late wife, Diana, helped to found UCLA's Jonsson Comprehensive Cancer Center, died March 15 at his Pacific Palisades home. He was 79. Jonsson made his first donation to support cancer research more than four decades ago in the 1960s.
Jonsson Comprehensive Cancer Center March 16, 2010
More... | Submit News Release | Advertising...
|
New Job Postings...
Free Job Posting Trial Offer
More... |
Job Advertising...
| About Job Postings...
|
New Facilities Available...
ATC clean room constructors...validation guaranteed!
More... |
Facility Advertising...
|
Upcoming Events...
 More... |
Submit Event |
Event Advertising...
|
|
Learn About Utah's BioHistory
Why is there a life science industry in Utah? Is the industry
growing? What do other states have?
Through Utah BioHistory, you can learn about the scientists,
institutions, political leaders, and significant events that have shaped and are still shaping
the biotechnology, medical device and life science industry in Utah.
More...
BioEvolution Posters
More...
March - National Colorectal Cancer Awareness Month
As a leading health organization for 25 years, the Prevent Cancer Foundation, the vision of Carolyn Aldigé, has
catapulted cancer prevention to prominence and provided more than $113 million in support of cancer prevention
and early detection research, education and community outreach programs across the country.
More...
BioFact
(1983) - The U.S. National Plant Germplasm System's total budget is just over $10 million. This amounts to .02% of the USDA's total budget for 1983 and is 500 times less than the 10% the USDA spent on comparable activities in 1921.
It's a Small World
|
| |
Dendrite
| |
Science Quote
"Science is a wonderful thing if one does not have to earn one's living at it."
| - |
Albert Einstein
|
|
(1879-1955)
|
|
